Proteomic and Functional Analysis of the Effects of Quinoxaline Derivatives on


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2022
Historique:
received: 01 03 2022
accepted: 23 05 2022
entrez: 14 7 2022
pubmed: 15 7 2022
medline: 16 7 2022
Statut: epublish

Résumé

Quinoxalines are heterocyclic compounds that contain a benzene ring and a pyrazine ring. The oxidation of both nitrogen of the pyrazine ring results in quinoxaline derivatives (QdNO), which exhibit a variety of biological properties, including antiparasitic activity. However, its activity against

Identifiants

pubmed: 35832378
doi: 10.3389/fcimb.2022.887647
pmc: PMC9271875
doi:

Substances chimiques

Pyrazines 0
Quinoxalines 0
Reactive Oxygen Species 0
Thioredoxin-Disulfide Reductase EC 1.8.1.9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

887647

Informations de copyright

Copyright © 2022 Avila-Bonilla, López-Sandoval, Soto-Sánchez, Marchat, Rivera, Medina-Contreras and Ramírez-Moreno.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Exp Parasitol. 1998 Nov;90(3):262-9
pubmed: 9806871
Parasitol Res. 2020 Feb;119(2):695-711
pubmed: 31907668
Sci Rep. 2017 Oct 9;7(1):12854
pubmed: 28993644
J Genet Genomics. 2012 Apr 20;39(4):167-71
pubmed: 22546538
Biochem J. 2013 Apr 15;451(2):277-88
pubmed: 23398389
J Infect Dis. 1981 Dec;144(6):539-46
pubmed: 6276476
Front Cell Infect Microbiol. 2018 May 29;8:179
pubmed: 29896453
J Infect Dis. 1997 Dec;176(6):1597-602
pubmed: 9395373
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Eukaryot Cell. 2008 Jul;7(7):1222-6
pubmed: 18281599
Arch Invest Med (Mex). 1978;9 Suppl 1:219-22
pubmed: 211953
J Antimicrob Chemother. 2012 Feb;67(2):375-86
pubmed: 22110087
Parasitol Today. 1993 May;9(5):187-90
pubmed: 15463750
J Histochem Cytochem. 1972 Dec;20(12):1006-23
pubmed: 4640962
Bioorg Med Chem. 2013 Aug 1;21(15):4550-8
pubmed: 23787289
Drug Metab Dispos. 2014 Apr;42(4):511-9
pubmed: 24440959
J Biol Chem. 2005 Sep 16;280(37):32168-76
pubmed: 16027148
Acta Crystallogr F Struct Biol Commun. 2015 May;71(Pt 5):594-9
pubmed: 25945714
PLoS One. 2014 Jan 17;9(1):e85706
pubmed: 24465654
PLoS Negl Trop Dis. 2008;2(8):e282
pubmed: 18846235
J Proteomics. 2015 Jan 01;112:125-40
pubmed: 25109464
Bioorg Chem. 2012 Apr-Jun;41-42:1-5
pubmed: 22245018
Eur J Obstet Gynecol Reprod Biol. 2005 Dec 1;123(2):174-8
pubmed: 16316810
Parasitol Res. 2018 Jan;117(1):45-58
pubmed: 29159705
J Cancer Res Clin Oncol. 2013 Aug;139(8):1279-94
pubmed: 23604466
Drug Discov Today Technol. 2004 Dec;1(3):189-95
pubmed: 24981484
Eur J Med Chem. 2004 Feb;39(2):195-203
pubmed: 14987828
Molecules. 2017 Feb 01;22(2):
pubmed: 28157150
J Biol Chem. 2002 May 17;277(20):18161-72
pubmed: 11867631
Proc Biol Sci. 2003 Nov 7;270 Suppl 2:S168-71
pubmed: 14667372
Clin Microbiol Rev. 2001 Jan;14(1):150-64
pubmed: 11148007
Antimicrob Agents Chemother. 2016 May 23;60(6):3433-44
pubmed: 27001812
J Cell Sci. 1999 Apr;112 ( Pt 8):1191-201
pubmed: 10085254
Exp Parasitol. 2008 Dec;120(4):403-10
pubmed: 18845147
Front Microbiol. 2015 Sep 30;6:975
pubmed: 26483758
Eur J Med Chem. 2018 Oct 5;158:68-81
pubmed: 30199706
J Natl Cancer Inst. 1972 Mar;48(3):721-9
pubmed: 5058971
Mol Biochem Parasitol. 2004 Feb;133(2):187-96
pubmed: 14698431
Org Biomol Chem. 2009;7:3040-3048
pubmed: 21359112
Pharmazie. 2003 Jan;58(1):68-9
pubmed: 12622258
Trans R Soc Trop Med Hyg. 1978;72(4):431-2
pubmed: 212851
Parasitology. 2018 Sep;145(11):1378-1387
pubmed: 29565001
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
Cells. 2017 Nov 21;6(4):
pubmed: 29160807
J Biol Chem. 2013 Jul 19;288(29):20966-20977
pubmed: 23737525
PLoS Pathog. 2020 May 7;16(5):e1008214
pubmed: 32379809

Auteurs

Rodolfo Gamaliel Avila-Bonilla (RG)

Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía, Laboratorio de Biomedicina Molecular 2, México City, Mexico.

Ángel López-Sandoval (Á)

Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía, Laboratorio de Biomedicina Molecular 2, México City, Mexico.

Jacqueline Soto-Sánchez (J)

Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía, Laboratorio de Biomedicina Molecular 2, México City, Mexico.

Laurence A Marchat (LA)

Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía, Laboratorio de Biomedicina Molecular 2, México City, Mexico.

Gildardo Rivera (G)

Instituto Politécnico Nacional, Centro de Biotecnología Genómica, Laboratorio de Biotecnología Farmacéutica, Reynosa, Mexico.

Oscar Medina-Contreras (O)

Hospital Infantil de México Federico Gómez, Unidad de Investigación Epidemiológica en Endocrinología y Nutrición (UIEEN), México City, Mexico.

Esther Ramírez-Moreno (E)

Instituto Politécnico Nacional, Escuela Nacional de Medicina y Homeopatía, Laboratorio de Biomedicina Molecular 2, México City, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH